UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Periodontal therapeutics: Current host‐modulation agents and future directions

Periodontology 2000, 2020-02, Vol.82 (1), p.186-204

2020

Volltextzugriff (PDF)

Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

Frontiers in immunology, 2019-07, Vol.10, p.1664

2019

Volltextzugriff (PDF)

A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization

Scientific reports, 2023-09, Vol.13 (1), p.15513-15513, Article 15513

2023

Volltextzugriff (PDF)

Dose‐response assessment of chemically modified curcumin in experimental periodontitis

Journal of periodontology (1970), 2019-05, Vol.90 (5), p.535-545

2019

Volltextzugriff (PDF)

pKa, zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins

Current medicinal chemistry, 2012-09, Vol.19 (25), p.4367-4375

2012

Volltextzugriff (PDF)

Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis

Archives of oral biology, 2018-07, Vol.91, p.42-50

2018

Volltextzugriff (PDF)

Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

Annals of medicine (Helsinki), 2006-01, Vol.38 (5), p.306-321

2006

Volltextzugriff (PDF)

Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases

International dental journal, 2016-06, Vol.66 (3), p.127-135

2016

Volltextzugriff (PDF)

The Link Between Periodontitis and Rheumatoid Arthritis: A Periodontist’s Perspective

Current oral health reports, 2015-03, Vol.2 (1), p.20-29

2015

Volltextzugriff (PDF)

An Unexplored Pharmacologic/Diagnostic Strategy for Peri-Implantitis: A Protocol Proposal

Diagnostics (Basel), 2020-12, Vol.10 (12), p.1050

2020

Volltextzugriff (PDF)

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation

Pharmacological research, 2011-12, Vol.64 (6), p.573-579

2011

Volltextzugriff (PDF)

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial

The Journal of the American Dental Association (1939), 2011-03, Vol.142 (3), p.262

2011

Volltextzugriff (PDF)

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

Journal of experimental pharmacology, 2020-02, Vol.12, p.47-60

2020

Volltextzugriff (PDF)

Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine

Journal of Oral Microbiology, 2012, Vol.4 (1), p.19227-14

2012

Volltextzugriff (PDF)

In Vitro Study of the Effects of Five Chemically Modified Tetracycline (CMT) Analogs on Human Epidermal Melanogenesis: Potential as Novel Anti-Melanogenic Agents

Drugs and drug candidates, 2023-10, Vol.2 (4), p.810-826

2023

Volltextzugriff (PDF)

Host modulation therapy in periodontitis, diagnosis and treatment—status update

Frontiers in dental medicine, 2024-07, Vol.5

2024

Volltextzugriff (PDF)

Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic

Expert review of proteomics, 2021-08, Vol.18 (8), p.707-717

2021

Volltextzugriff (PDF)

Introduction and background

Pharmacological research, 2011-02, Vol.63 (2), p.99-101

Golub, Lorne M

2011

Volltextzugriff (PDF)

Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinic

Pharmacological research, 2011-02, Vol.63 (2), p.121-129

2011

Volltextzugriff (PDF)

Periodontal disease in acute coronary syndrome patients

American journal of dentistry, 2021-04, Vol.34 (2), p.97

2021

Volltextzugriff (PDF)

Metalloproteinase Inhibitors, Nonantimicrobial Chemically Modified Tetracyclines, and Ilomastat Block Bacillus anthracis Lethal Factor Activity in Viable Cells

Infection and Immunity, 2005-11, Vol.73 (11), p.7548-7557

2005

Volltextzugriff (PDF)

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

Inflammation, 2017-08, Vol.40 (4), p.1436-1449

2017

Volltextzugriff (PDF)

DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN

Shock (Augusta, Ga.), 2016-04, Vol.45 (4), p.375-384

2016

Volltextzugriff (PDF)

Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss

Journal of inflammation research, 2023-01, Vol.16, p.779-792

2023

Volltextzugriff (PDF)

A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis

Journal of inflammation research, 2021-01, Vol.14, p.5337-5347

2021

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(104)
Tagungsberichte
(1)

Sprache

Englisch
(105)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(70)
Humans
(49)
Animals
(38)
Biological And Medical Sciences
(28)
Periodontitis
(25)
Dentistry
(24)
Dentistry, Oral Surgery & Medicine
(24)
Medical Sciences
(24)
Tetracyclines - Pharmacology
(24)
Female
(18)
Matrix Metalloproteinase Inhibitors
(16)
Inflammation
(15)
Rats
(15)
Tetracyclines - Therapeutic Use
(14)
Biochemistry & Molecular Biology
(13)
Doxycycline - Administration & Dosage
(13)
Pharmacology & Pharmacy
(13)
Pharmacology. Drug Treatments
(13)
Matrix Metalloproteinases
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Periodontal therapeutics: Current host‐modulation agents and future directions

Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization

Dose‐response assessment of chemically modified curcumin in experimental periodontitis

pKa, zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins

Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis

Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases

The Link Between Periodontitis and Rheumatoid Arthritis: A Periodontist’s Perspective

An Unexplored Pharmacologic/Diagnostic Strategy for Peri-Implantitis: A Protocol Proposal

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine

In Vitro Study of the Effects of Five Chemically Modified Tetracycline (CMT) Analogs on Human Epidermal Melanogenesis: Potential as Novel Anti-Melanogenic Agents

Host modulation therapy in periodontitis, diagnosis and treatment—status update

Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic

Introduction and background

Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinic

Periodontal disease in acute coronary syndrome patients

Metalloproteinase Inhibitors, Nonantimicrobial Chemically Modified Tetracyclines, and Ilomastat Block Bacillus anthracis Lethal Factor Activity in Viable Cells

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN

Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss

A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis

Aktive Filter

Suchergebnisse filtern